title: Short-time pretreatment of rosuvastatin attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression.
authors.affiliation: Department of Cardiology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, China.
authors.forename: Bing
authors.initials: B
authors.lastname: Wu
authors.forename: Zhijun
authors.initials: Z
authors.lastname: Su
authors.forename: Rong
authors.initials: R
authors.lastname: Lin
authors.forename: Ruozhu
authors.initials: R
authors.lastname: Dai
authors.forename: Chengbo
authors.initials: C
authors.lastname: Chen
authors.forename: Haiyun
authors.initials: H
authors.lastname: Wu
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D005464:Fluorobenzenes / Q000627:therapeutic use*; D024243:HMGB1 Protein / Q000187:drug effects / Q000378:metabolism*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D017202:Myocardial Ischemia / Q000517:prevention & control*; D018384:Oxidative Stress; D011292:Premedication; D011743:Pyrimidines / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000517:prevention & control*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D015415:Biomarkers; D005464:Fluorobenzenes; D024243:HMGB1 Protein; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D008315:Malondialdehyde; D000068718:Rosuvastatin Calcium; D013482:Superoxide Dismutase
keywords: High mobility group box 1 protein; Myocardial ischemia; Reperfusion; Rosuvastatin